Morgan Stanley’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,044,367
Closed -$28.7M – 8183
2022
Q3
$28.7M Sell
1,044,367
-4,853,988
-82% -$120M ﹤0.01% 1816
2022
Q2
$136M Sell
5,898,355
-3,049,486
-34% -$71.2M 0.02% 756
2022
Q1
$195M Sell
8,947,841
-418,286
-4% -$8.68M 0.03% 540
2021
Q4
$200M Buy
9,366,127
+5,199,541
+125% +$109M 0.02% 569
2021
Q3
$87.2M Buy
4,166,586
+1,115,119
+37% +$24.3M 0.01% 918
2021
Q2
$70.3M Buy
3,051,467
+225,710
+8% +$5.19M 0.01% 1072
2021
Q1
$62.4M Buy
2,825,757
+2,480,081
+717% +$57.4M 0.01% 1023
2020
Q4
$6.45M Buy
345,676
+101,276
+41% +$1.66M ﹤0.01% 2988
2020
Q3
$3.55M Buy
244,400
+2,237
+0.9% +$28.4K ﹤0.01% 3068
2020
Q2
$2.71M Buy
242,163
+134,948
+126% +$1.52M ﹤0.01% 3296
2020
Q1
$1.07M Buy
107,215
+98,318
+1,105% +$1.37M ﹤0.01% 3902
2019
Q4
$146K Sell
8,897
-10,326
-54% -$139K ﹤0.01% 5526
2019
Q3
$232K Sell
19,223
-88,256
-82% -$1.21M ﹤0.01% 5060
2019
Q2
$1.57M Buy
+107,479
New +$1.59M ﹤0.01% 3963

Other funds holding CHNG

Morgan Stanley's CHNG Position: Q4 2022 in Review

Morgan Stanley sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 1,044,367 shares — an estimated $28.7M sold.

Morgan Stanley first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $200M in Q4 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Morgan Stanley reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 1,044,367 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $28.7M.
  • Morgan Stanley first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Morgan Stanley's Change Healthcare Inc. Common Stock position peaked at $200M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.